Auctus Fund Management LLC 13D and 13G filings for BioRestorative Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 12:33 pm Purchase |
2024-09-30 | 13G | BioRestorative Therapies, Inc. BRTX |
Auctus Fund Management LLC | 692,418 9.900% |
210,103 (+43.56%) |
Filing |
| 2024-02-14 1:44 pm Purchase |
2023-12-31 | 13G | BioRestorative Therapies, Inc. BRTX |
Auctus Fund Management LLC | 482,315 9.900% |
106,311 (+28.27%) |
Filing |
| 2023-02-14 1:02 pm Purchase |
2022-12-31 | 13G | BioRestorative Therapies, Inc. BRTX |
Auctus Fund Management LLC | 376,004 9.900% |
166,004 (+79.05%) |
Filing |
| 2022-07-14 5:26 pm Purchase |
2022-06-30 | 13G | BioRestorative Therapies, Inc. BRTX |
Auctus Fund Management LLC | 210,000 5.800% |
210,000 (New Position) |
Filing |